| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5929056 | American Heart Journal | 2011 | 30 Pages |
Abstract
In this observational study of patients with ACS, the use of evidence-based pharmacologic therapies for ACS was quite high, yet 39% of eligible patients with STEMI received no reperfusion therapy. These findings suggest opportunities to further reduce the risk of long-term ischemic events in patients with ACS in developing countries.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
The ACCESS Investigators The ACCESS Investigators,